Mike Tyson's TYSON 2.0 Collaborates with Holiday to Launch Marijuana E-cigarettes

Market by 2FIRSTS.ai
Jul.17.2024
Mike Tyson's TYSON 2.0 Collaborates with Holiday to Launch Marijuana E-cigarettes
Mike Tyson's cannabis brand TYSON 2.0 partners with Holiday to launch marijuana e-cigarette series in New York.

According to a report from Benzinga on July 16, boxing champion Mike Tyson's cannabis brand TYSON 2.0 has announced a partnership with e-cigarette manufacturer Holiday to launch a cannabis e-cigarette series in New York.

 

This new partnership announced on Tuesday (16th) has launched three flavors of disposable e-cigarettes, including Knockout OG, Haymaker Haze, and Gelato 44.

 

Tyson stated that

 

Collaborating with Holiday to create these new e-cigarette products was an incredible experience. Each flavor reflects our commitment to quality and the unique characteristics of my favorite cannabis strains. We are excited to offer customers something truly special, and I believe these e-cigarettes will be a game-changer.

 

The CEO of Carma HoldCo, the parent company of TYSON 2.0, Adam Wilks, stated

 

By combining the strengths of Tyson 2.0 and Holiday, we are able to provide products that not only meet but exceed consumer expectations. This disposable e-cigarette series proves our commitment to innovation and quality.

 

This new product can be purchased at specific pharmacies in New York, including Strain Stars, MJ Dispensary, FlynnStoned Cannabis Company, Leafy Peaks, Housing Works Cannabis Co, and Culture House Dispensary.

 

Tyson and Carma HoldCo have launched their cannabis brand TYSON 2.0 in New York for the first time in 2023 through a partnership with Hudson Cannabis.

 

As a native New Yorker, I am excited to bring Tyson 2.0 to my hometown. This brand represents my personal journey towards overall health and my belief in cannabis promoting a balanced lifestyle.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

KT&G Moves Ahead With Oral Nicotine Product Development and Pilot Line Preparation
KT&G Moves Ahead With Oral Nicotine Product Development and Pilot Line Preparation
According to a Korean media report, KT&G is developing a smokeless nicotine product that delivers nicotine through oral absorption and is preparing a pilot production line for research and development.
Apr.08 by 2FIRSTS.ai
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Group reported its first-quarter 2026 results on April 30. Net revenues were $5.43 billion, up 3.2% year on year, while revenues net of excise taxes were $4.76 billion, up 5.3%. Reported diluted EPS was $1.30, up more than 100%, and adjusted diluted EPS was $1.32, up 7.3%.
May.06 by 2FIRSTS.ai
FDA Says It Will Not Take Enforcement Action Against Zone Nicotine Pouches Until Lawsuit Is Resolved
FDA Says It Will Not Take Enforcement Action Against Zone Nicotine Pouches Until Lawsuit Is Resolved
The U.S. Food and Drug Administration has told vape manufacturer Fontem US that it does not presently intend to take enforcement action against the company’s Zone nicotine pouches while litigation over the agency’s handling of the application remains unresolved.
Apr.07 by 2FIRSTS.ai
Azerbaijan Cancels E-Cigarette State Standard as Full Vape Ban Takes Effect on April 1
Azerbaijan Cancels E-Cigarette State Standard as Full Vape Ban Takes Effect on April 1
The Azerbaijan Institute of Standardization (AZSTAND) has announced the cancellation of state standard AZS 941:2023, “Electronic Cigarettes. General Technical Specifications.”Under legal amendments adopted on December 30, 2025, Azerbaijan has prohibited from April 1, 2026 the import, export, manufacture, storage, wholesale and retail sale, and use of e-cigarettes and their components.
Apr.07 by 2FIRSTS.ai
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
According to Reuters, major tobacco companies may emerge as key beneficiaries after the U.S. FDA loosened regulations on vaping and nicotine pouch products, a shift that has sparked debate over public health risks.
Industry Insight
May.26
Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
U.S. Smokeless Tobacco Company (USSTC), a subsidiary of Altria Group, announced plans to close its Nashville manufacturing facility by 2028 and consolidate production operations at a new facility in Hopkinsville, Kentucky.
Market
Jun.02